![](https://investorshub.advfn.com/uicon/607320.png?cb=1602587228)
Tuesday, July 11, 2017 6:46:59 PM
Real Life Possibility: I can see something like this scenario having occurred.
Pfizer: Hello IPIX, I love the possible MOA of Kevetrin. Do you mind if we sign a CDA and watch closely as you go thru your phase 1 trial at Dana Farber?
IPIX: Sure, we would be delighted and honored for you to take a closer look!
Years pass during the Phase 1:
Pfizer: Wow, what fascinating data and possibilities, especially with the disappearance of those tumors in that Ovarian Cancer patient. We feel the need for you to prove the MOA however and we need an even closer look at what effects Kevetrin has on the tumor itself and need some biopsies. Please rearrange your trial design to these conditions... xYZ
IPIX: Sure we are up for the challenge and believe in Kevetrin.
Pfizer: Wow, Brilacidin looks extremely powerful, can we sign a CDA for that as well?
IPIX: Absolutely! We have 3 other Big Pharm on CDA as well for Brilacidin, but please come take a look!
Pfizer: Internal meeting: Wholly "SHI!" team, this Kevetrin and Brilacidin could be blockbusters and not only for one indication, multiple!!! IPIX keeps turning in promising data, set after set! This might get very expensive if we wait around much longer, lets try and get this done with an initial offer: Hi IPIX, we are willing to buy your company for 6 Billion dollars. Take it or leave it.
IPIX: Oh my! That is a great offer and we are honored! However, we have not even come close to the realization of the FULL potential of Kevetrin or Brilacidin yet. Not to mention we are going full speed ahead with an Oral Psoriasis drug that could compete with Biologics. That 6 Billion is just not what we are looking for as an end goal. We have much more to do to maximize our value. But thank you!
Pfizer: Crap!
As time passes - more and more CDA's are signed and more interest and meetings have taken place.
Pfizer: Internal Meeting: Team - we need to make decision on how we want to attack this. This company could have 3 drugs alone that could bring in over 20 billion a year when all said and done...possibly much more! Should we step up or lose our opportunity?
IPIX: Leo and Dr. M and Dr. B, all working hard - day in and day out. Drowning out the noise and simply getting it done. Trial after Trial. Waiting for that offer that they cannot resist.
LOL - I am just saying. There is alot going on behind the scenes. And one day we WILL wake up to something that is more than amazing IMO.
Thursday - I hope for 4 out 5 FULL remission.
Good luck!
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM